148 related articles for article (PubMed ID: 15774801)
21. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement.
Bartlett DL; Berlin J; Lauwers GY; Messersmith WA; Petrelli NJ; Venook AP
Ann Surg Oncol; 2006 Oct; 13(10):1284-92. PubMed ID: 16955384
[No Abstract] [Full Text] [Related]
22. Hepatic arterial infusion chemotherapy for metastases from colorectal cancer: is it really the end of an era?
D'Angelica M; Fong Y; DeMatteo RP; Jarnagin WR
J Clin Oncol; 2008 Jun; 26(16):2788-9; author reply 2789-90. PubMed ID: 18509192
[No Abstract] [Full Text] [Related]
23. Treatment of liver metastases from colorectal cancer with continuous high dose intra-arterial floxuridine (FUDR) and systemic fluorouracil: a phase II study.
Planting AS; Runhaar EA; Verwey J; Taal BG; Blijham G; Neyt JP
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1887-8. PubMed ID: 2534382
[No Abstract] [Full Text] [Related]
24. [Pre-operative chemotherapy for patients with hepatic metastases from colorectal cancer].
Gu J; Yao YF
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):158-9. PubMed ID: 17645861
[No Abstract] [Full Text] [Related]
25. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
Kemeny N; Cohen A; Seiter K; Conti JA; Sigurdson ER; Tao Y; Niedzwiecki D; Botet J; Budd A
J Clin Oncol; 1993 Feb; 11(2):330-5. PubMed ID: 8426211
[TBL] [Abstract][Full Text] [Related]
26. Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases.
Litvak DA; Wood TF; Tsioulias GJ; Chung M; Chawla SP; Foshag LJ; Morton DL; Ramming KP; Bilchik AJ
Ann Surg Oncol; 2002 Mar; 9(2):148-55. PubMed ID: 11888871
[TBL] [Abstract][Full Text] [Related]
27. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
28. [Quality of life and survival after continuous intrahepatic floxuridine infusions in liver metastases of colorectal carcinomas].
Lorenz M; Hanisch E
Z Gastroenterol; 1995 Nov; 33(11):679-80. PubMed ID: 8600667
[No Abstract] [Full Text] [Related]
29. [Evidence for and practical use of arterial infusion chemotherapy for liver metastases].
Arai Y; Matsueda K; Inaba Y; Aramaki T
Gan To Kagaku Ryoho; 2002 Feb; 29(2):182-8. PubMed ID: 11865622
[TBL] [Abstract][Full Text] [Related]
30. [European topic: liver surgery II--regional chemotherapy].
Hottenrott C; Lorenz M
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():273-7. PubMed ID: 2577555
[TBL] [Abstract][Full Text] [Related]
31. [Hepatic arterial infusion chemotherapy for liver metastases from digestive cancer].
Arai Y; Takeuchi Y; Inaba Y; Yamaura H; Sato Y; Aramaki T; Seki H; Matsueda K
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1231-5. PubMed ID: 16969016
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement by Bartlett et al.
Chari RS; Helton WS; Marsh RD
Ann Surg Oncol; 2006 Oct; 13(10):1293-5. PubMed ID: 16952023
[No Abstract] [Full Text] [Related]
33. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
34. [A case of hepatic metastasis and local recurrence from rectal cancer responding to hepatic arterial infusion and systemic chemotherapy].
Kato T; Kikkawa N; Tsujie M; Iijima S; Handa R; Naoi Y; Oshima S; Yamamoto H; Kurokawa E
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1729-32. PubMed ID: 14619505
[TBL] [Abstract][Full Text] [Related]
35. Unresectable hepatic colorectal metastases: need for new surgical strategies.
Vauthey JN; Abdalla EK
Ann Surg Oncol; 2006 Jan; 13(1):5-6. PubMed ID: 16372151
[No Abstract] [Full Text] [Related]
36. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues.
Patt YZ
J Clin Oncol; 1993 May; 11(5):815-9. PubMed ID: 8487044
[No Abstract] [Full Text] [Related]
37. First-line hepatic infusion of pirarubicin in patients with isolated liver metastases: is it really promising?
Fakih M
Ann Oncol; 2004 Feb; 15(2):359. PubMed ID: 14760138
[No Abstract] [Full Text] [Related]
38. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
[TBL] [Abstract][Full Text] [Related]
39. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
[TBL] [Abstract][Full Text] [Related]
40. Complete response of colorectal liver metastases after intra-arterial chemotherapy.
Fiorentini G; Del Conte A; De Simone M; Guadagni S; Mambrini A; D'Alessandro M; Aliberti C; Rossi G; Cantore M
Tumori; 2008; 94(4):489-92. PubMed ID: 18822683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
